Akero Therapeutics Inc. (AKRO)

NASDAQ: AKRO · Real-Time Price · USD

45.42

-0.19 (-0.42%)

At close: May 01, 2025, 3:59 PM

45.75

0.72%

Pre-market: May 02, 2025, 07:56 AM EDT

Akero Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	340.24M	234.21M	249.77M	150.48M	187.24M	136.4M	75.97M	598K
Short-Term Investments	402.84M	315.8M	101.68M	37.77M	81.14M	71.61M	n/a	n/a
Long-Term Investments	54.75M	19.28M	n/a	n/a	40K	40K	20K	20K
Other Long-Term Assets	n/a	n/a	108K	417K	161K	29K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	27.3M	9.95M	3.72M	5.32M	2.96M	1.65M	1.16M	40K
Total Current Assets	770.38M	559.96M	355.17M	193.58M	271.35M	138.05M	77.13M	638K
Property-Plant & Equipment	755K	1.03M	1.29M	1.55M	1.79M	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	55.51M	20.31M	1.4M	1.97M	1.99M	69K	20K	20K
Total Assets	825.89M	580.27M	356.57M	195.55M	273.34M	138.12M	77.15M	658K
Account Payables	9.03M	7.04M	7.97M	6.71M	3.43M	947K	1.37M	60K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	30.1M	1.3M	9.99M	17.66M	495K	6.73M	665K	2K
Total Current Liabilities	39.75M	19.13M	19.08M	25.13M	13.11M	9.37M	2.34M	222K
Long-Term Debt	529K	24.96M	9.54M	1.31M	1.52M	n/a	n/a	n/a
Other Long-Term Liabilities	34.96M	54K	305K	-1.31M	-1.52M	23K	124.73M	5M
Total Long-Term Liabilities	36.02M	25.84M	10.93M	1.31M	1.52M	23K	124.73M	5M
Total Liabilities	75.77M	44.97M	30.01M	26.44M	14.63M	9.39M	127.07M	5.22M
Total Debt	36.46M	26.3M	10.95M	1.52M	1.81M	n/a	n/a	n/a
Common Stock	7K	6K	5K	4K	4K	3K	n/a	n/a
Retained Earnings	-826.16M	-574.1M	-422.34M	-310.3M	-209.53M	-130.32M	-86.56M	-4.56M
Comprehensive Income	948K	270K	37K	-27K	-3K	-6K	n/a	n/a
Shareholders Equity	750.11M	535.31M	326.56M	169.11M	258.71M	128.73M	-49.92M	-4.56M
Total Investments	457.59M	335.09M	101.68M	37.77M	81.14M	71.61M	20K	20K